Viral Targeted Gene Therapy and Hepatocellular Carcinoma: Possible Therapeutic Prospects and Drawbacks

Journal Title: Journal of Advances in Microbiology - Year 2017, Vol 5, Issue 1

Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of liver cancer-related death in humans; it can be a malignant or localized tumor of liver cells (hepatocytes) and development is by a multistep complex process called Hepatocarcinogenesis. Etiological agents of HCC include liver cirrhosis, chronic hepatitis due to hepatitis B virus and or hepatitis C virus infection, alcoholism, exposure to dietary carcinogenic aflatoxins and hemochromatosis. HCC may also result from production of aberrant hepatocytes and the formation of dysplastic nodules. Recent researches have revealed the involvement of aberrant microRNA (miRNA) expression and liver-specific cancer stem cells (CSCs) in HCC development. The progression of hepatocarcinogenesis is associated with multiple molecular mechanisms that involve genetic, epigenetic, and cell signaling alterations. DNA Methylation, an important epigenetic event in human carcinogenesis has been studied extensively to understand the mechanisms underlying HCC progression for optimized clinical management of HCC and the development of new therapeutic approaches to the disease. Despite current progress with the treatment of human cancers, existing therapies are limited in their abilities to cure HCC and fatality still remains high. Hence, this review critically examine the prospects of viral targeted gene therapy for effective management of HCC and the current drawbacks encountered in the use of viral vectors for immunotherapy of various human metastatic cancer stem cell forms.

Authors and Affiliations

O. I. Afolami, A. K. Onifade

Keywords

Related Articles

Antibiotic Susceptibility Profile of Bacterial Pathogens Isolated from Malabor Hostel Tap Water, Calabar- Nigeria

The antibiotic resistance and susceptibility profiles of some bacterial isolates including Listeria monocytogenes, Erwinia stewartii, Legionella pneumophilia, Carnobacterium gallinarum, Staphylococcus caseolyticus, Enter...

Extraction and Characterization of Staphylococcins from S. aureus Isolated from Selected Environments within Akure Metropolis and Evaluation of Their Antibacterial Activity

Staphylococcins are bacteriocins produced by Staphylococcus aureus and it has been proven that they have antibacterial potential. The purpose of this study was to compare the staphylococcin producing potential of S. aure...

Aspergillus Xylanases

There has been tremendous growth and development in the use of xylanase in the biotechnology industry. The market trends reveal that xylanase takes major position of share up to 20% of the world enzymes market along with...

Phytochemical and Antimicrobial Activity Screening of Ether Extract of Afromomum melegueta Seed

Aim: The search for new antimicrobials as a result of antibiotic failure has led to the development of new antibiotic scaffolds. In the African sub-continent, this has translated to exploration of her rich flora for pote...

Antibacterial Activity of Sida cuneifolia Vollesen against Staphylococcus aureus

Background: Sida cuneifolia is utilized traditionally to treat many ailments yet as far as we know its medicinal properties have not been scientifically tested locally in Kenya. The aim of the present study was therefore...

Download PDF file
  • EP ID EP338138
  • DOI 10.9734/JAMB/2017/35944
  • Views 80
  • Downloads 0

How To Cite

O. I. Afolami, A. K. Onifade (2017). Viral Targeted Gene Therapy and Hepatocellular Carcinoma: Possible Therapeutic Prospects and Drawbacks. Journal of Advances in Microbiology, 5(1), 1-6. https://europub.co.uk/articles/-A-338138